Literature DB >> 6279015

Racial differences in intact erythrocyte ion transport.

J F Hennessy, K P Ober.   

Abstract

Epidemiologic studies indicate a much higher incidence of hypertension in blacks than in whites, although no clear biochemical correlates to account for such overt racial differences have been identified. In recent years, considerable evidence has linked perturbations in ion transport to the risk of developing hypertension. Potassium (K+) transport and the ouabain-sensitive component of K+ transport in the erythrocyte were measured in 54 healthy, age and sex matched black and white subjects. Blacks have a significantly (p less than 0.001) lower capacity for K+ transport (0.190 +/- 0.03 mumoles K+ per hr per 10(9) red blood cells [RBC] than whites (0.230 +/- 0.03 mumoles K+ per hr 10(9) RBC) with a significantly (p less than 0.001) higher percentage of K+ transport dependent upon ouabain-sensitive mechanisms (blacks 85.26 +/- 4.14 percent versus whites 76.69 +/- 6.67 percent). These data clearly define overt racial differences in K+ transport which suggest that blacks have a more limited capacity to exchange intracellular sodium for extracellular K+, and a higher percentage of that exchange is dependent upon ouabain-sensitive mechanisms. These findings need be kept in mind were clinical studies of ion transport are being assessed and may be germane to the increased prevalence in blacks for the development of hypertension.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279015

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  2 in total

Review 1.  Erythrocyte concentrations and transmembrane fluxes of sodium and potassium in essential hypertension: role of intrinsic and environmental factors.

Authors:  P Lijnen; J R M'Buyamba-Kabangu; R Fagard; J Staessen; A Amery
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 2.  Alterations in sodium metabolism as an etiological model for hypertension.

Authors:  P Lijnen
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.